Relief Therapeutics Holding Balance Sheet Health
Financial Health criteria checks 5/6
Relief Therapeutics Holding has a total shareholder equity of CHF49.3M and total debt of CHF12.0K, which brings its debt-to-equity ratio to 0.02%. Its total assets and total liabilities are CHF70.9M and CHF21.7M respectively.
Key information
0.02%
Debt to equity ratio
CHF 12.00k
Debt
Interest coverage ratio | n/a |
Cash | CHF 10.73m |
Equity | CHF 49.27m |
Total liabilities | CHF 21.65m |
Total assets | CHF 70.92m |
Recent financial health updates
We Think Relief Therapeutics Holding (VTX:RLF) Can Easily Afford To Drive Business Growth
Oct 09Health Check: How Prudently Does Relief Therapeutics Holding (VTX:RLF) Use Debt?
May 05Does Relief Therapeutics Holding (VTX:RLF) Have A Healthy Balance Sheet?
Oct 04Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?
Apr 23Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?
Sep 25Recent updates
We Think Relief Therapeutics Holding (VTX:RLF) Can Easily Afford To Drive Business Growth
Oct 09Relief Therapeutics Holding SA's (VTX:RLF) Share Price Boosted 52% But Its Business Prospects Need A Lift Too
Sep 03Relief Therapeutics Holding SA (VTX:RLF) Surges 52% Yet Its Low P/S Is No Reason For Excitement
Sep 03Health Check: How Prudently Does Relief Therapeutics Holding (VTX:RLF) Use Debt?
May 05Does Relief Therapeutics Holding (VTX:RLF) Have A Healthy Balance Sheet?
Oct 04Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?
Apr 23Relief Therapeutics Holding (VTX:RLF) Has Debt But No Earnings; Should You Worry?
Sep 25We Wouldn't Rely On Relief Therapeutics Holding's (VTX:RLF) Statutory Earnings As A Guide
Jan 13Financial Position Analysis
Short Term Liabilities: RLF's short term assets (CHF14.7M) exceed its short term liabilities (CHF4.8M).
Long Term Liabilities: RLF's short term assets (CHF14.7M) do not cover its long term liabilities (CHF16.9M).
Debt to Equity History and Analysis
Debt Level: RLF has more cash than its total debt.
Reducing Debt: RLF's debt to equity ratio has reduced from 6.6% to 0.02% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RLF has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: RLF has sufficient cash runway for 1 years if free cash flow continues to reduce at historical rates of 21.2% each year.
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 08:11 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Relief Therapeutics Holding SA is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Alexandre Müller | Research Dynamics |
Bob Pooler | ValuationLAB AG |